Litigation funders are cashing in by taking advantage of the currency value plunge in the UK and the rest of Europe, paying the costs of plaintiffs’ lawsuits with the hope of turning a profit from verdicts and settlements at the tail end of the lawsuits, which typically take years to play out. Read more.
Sysco is accusing Burford of blocking it from retaining new lawyers after it discharged its original counsel, but Burford characterises this as a strategic move, saying it won’t stand in the way of Sysco hiring new lawyers, as long as the company agrees to cover any additional costs for substitute counsel.
Former US House Judiciary Committee Counsel Paul Taylor argues that third-party litigation funders are funding patent trolls, leading to lopsided patent litigation ending in unjust settlements.
A court filing has revealed that a GLS Capital affiliate and Law Finance Group are funding a patent infringement suit brought by Microspherix against Nexplanon, a contraceptive implant whose US sales were nearly 10% of Merck & Co. spinoff Organon & Co.’s 2022 revenue.
We’ll alert you to key situations and stories you should be aware of.
We deliver the important litigation finance news and analysis straight to your inbox each Monday morning.
The newsletter is always free.
